Bioenergetics of Acquired Cisplatin Resistant H1299 Non-Small Cell Lung Cancer and P31 Mesothelioma Cells

Oncotarget - United States
doi 10.18632/oncotarget.21885
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Acquired Differential Regulation of Caspase-8 in Cisplatin-Resistant Non-Small-Cell Lung Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2012English

Epigenetic Activation of FOXF1 Confers Cancer Stem Cell Properties to Cisplatin‑resistant Non‑small Cell Lung Cancer

International Journal of Oncology
Cancer ResearchOncology
2020English

The microRNA-200 Family Targets Multiple Non-Small Cell Lung Cancer Prognostic Markers in H1299 Cells and BEAS-2B Cells

International Journal of Oncology
Cancer ResearchOncology
2013English

Expression of Cyclin�B1, D1 and K in Non‑small Cell Lung Cancer H1299 Cells Following Treatment With Sulforaphane

Oncology Reports
MedicineCancer ResearchOncology
2018English

Cisplatin, Vinblastine, and Bleomycin in Inoperable Non-Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1985English

Expression of Multidrug Resistance Proteins and Accumulation of Cisplatin in Human Non-Small Cell Lung Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2005English

Cancer Stem Cells in Lung Cancer: Distinct Differences Between Small Cell and Non-Small Cell Lung Carcinomas

2011English

Cisplatin, Vindesine, and Concomitant Radiation Therapy for Unresectable Non-Small Cell Lung Cancer.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1991English

Oxymatrine and Cisplatin Synergistically Enhance Anti-Tumor Immunity of CD8+ T Cells in Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy